Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation

  • Yueh-Lun Lee,
  • Chih-Wei Chen,
  • Fu-Hwa Liu,
  • Yu-Wen Huang,
  • Huei-Mei Huang
  • Article
  • Metrics
  • Comments
  • Media Coverage

The affiliation for the first author is incorrect. Yueh-Lun Lee is affiliated with: Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Reference

  1. 1. Lee Y-L, Chen C-W, Liu F-H, Huang Y-W, Huang H-M (2013) Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation. PLoS ONE 8(4): e61939. pmid:23613979

Citation: Lee Y-L, Chen C-W, Liu F-H, Huang Y-W, Huang H-M (2017) Correction: Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation. PLoS ONE 12(10): e0186528. https://doi.org/10.1371/journal.pone.0186528

Published: October 11, 2017

Copyright: © 2017 Lee et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.